756–765.
Ware J. J. et al. From Men to Mice: CHRNA5/ CHRNA3 , Smoking
Behavior and Disease// Nicotine &Tobacco Research. 2012.
Kaur-Knudsen D. et al. CHRNA3 Genotype, Nicotine Dependence, Lung Function
and Disease in the General Population// European Respiratory Journal. 2012. Vol. 40.. 1538–1544.
Bierut L. J. et al. Variants in Nicotinic Receptors and Risk for Nicotine Dependence// The
American Journal of Psychiatry. 2008. Vol. 165. P. 1163–1171.
Sherva R. et al. Association of a Single Nucleotide Polymorphism in Neuronal
Acetylcholine Receptor Subunit Alpha5 (CHRNA5 ) with
Smoking Status and
with ‘Pleasurable Buzz’ During Early Experimentation with Smoking// Addiction. September 2008.
Vol. 103. No. 9. P. 1544–1552.
Janes A. C. et al. Association between CHRNA5 Genetic Variation at Rs16969968
and Brain Reactivity to Smoking Images in Nicotine Dependent Women// Drug and Alcohol
Dependence. 1 January 2012. Vol. 120. No. 1–3. P. 7–13.
Li M. D. The Genetics of Nicotine Dependence// Current Psychiatry Reports. 2006. Vol. 8.
P. 158–164.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5114a2.htm—
оценка опасности курения от
Министерства здравоохранения США.
Bornman M. S., du Plessis D. J. Smoking and Vascular Impotence. A Reason for Concern//
South African Medical Journal. 13 September 1986. Vol. 70. No. 6. P. 329–30.
Mamede M. et al.Temporal Change in Human Nicotinic Acetylcholine Receptor After
Smoking Cessation: 5IA SPECT Study// Journal of Nuclear Medicine. 2007. Vol. 48.
P. 1829–1835.
Taylor D. H. et al. Benefits of Smoking Cessation for Longevity// The American
Journal of
Public Health. June 2002. Vol. 92. No. 6. P. 990–996.
Kendall S. B. Preference for Intermittent Reinforcement// Journal of the Experimental
Analysis of Behavior. May 1974. Vol. 21. No. 3. P. 463–473.
Jorenby D. E. et al. Efficacy of Varenicline, an
α4β2Nicotinic Acetylcholine
Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation. A
Randomized Controlled Trial// JAMA. 2006. Vol. 296. No. 1. P. 56–63.
Moore D. et al. Effectiveness and Safety of Nicotine Replacement Therapy Assisted
Reduction to Stop Smoking: Systematic Review and Meta-Analysis //British Medical Journal. 2009.
Vol. 338.
Cornuz J. et al. A Vaccine Against Nicotine for Smoking Cessation: A Randomized
Controlled Trial// PLoS ONE 3 (6): e2547.
Hicks M. J. et al. AAV — Directed Persistent Expression
of a Gene Encoding
Anti-Nicotine Antibody for Smoking Cessation// Science Translational Medicine. 27 June 2012.
жүктеу/скачать
Достарыңызбен бөлісу: